Overview

HIV Risk Reduction and Drug Abuse Treatment in Malaysia

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
A randomized clinical trial comparing drug abuse and HIV risk reduction counseling (DC-HIV) alone, DC-HIV combined with naltrexone maintenance, and DC-HIV combined with buprenorphine maintenance for the treatment of heroin addicts in Malaysia.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Buprenorphine
Naltrexone